Fiera Capital (Canada)’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Sell
774,569
-193,026
-20% -$4.83M 0.06% 181
2026
Q1
$24.2M Buy
967,595
+691,101
+250% +$19.5M 0.08% 176
2025
Q4
$8.7M Buy
276,494
+63,192
+30% +$2.1M 0.03% 211
2025
Q3
$7.61M Sell
213,302
-5,376
-2% -$245K 0.02% 216
2025
Q2
$12.6M Buy
218,678
+2,610
+1% +$148K 0.04% 177
2025
Q1
$12.6M Sell
216,068
-9,642
-4% -$658K 0.05% 184
2024
Q4
$18.2M Buy
+225,710
New +$19.3M 0.06% 156

Other funds holding PRCT

Fiera Capital (Canada)'s PRCT Position: Q2 2026 in Review

Fiera Capital (Canada) reduced its Procept Biorobotics (PRCT) stake by 20% in Q2 2026, selling an estimated $4.83M and leaving 774,569 shares worth $17.5M. The position accounts for 0.06% of the portfolio, ranked #181.

Fiera Capital (Canada) first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.2M in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Fiera Capital (Canada) held 774,569 shares of Procept Biorobotics worth $17.5M as of Q2 2026.
  • Fiera Capital (Canada) sold 193,026 Procept Biorobotics shares in Q2 2026, an estimated $4.83M.
  • Procept Biorobotics made up 0.06% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #181 holding.
  • Fiera Capital (Canada) first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • Fiera Capital (Canada)'s Procept Biorobotics position peaked at $24.2M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.